By PTI
NEW DELHI: The Union well being ministry is anticipated to quickly approve Biological E’s Corbevax as a precaution dose for individuals above 18 years who’re double vaccinated with both Covishield or Covaxin, official sources stated on Tuesday.
The approval might be primarily based on the suggestions made by the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) final week, the sources instructed PTI.
If authorised by the federal government, this might be the primary time a booster dose of a Covid vaccine totally different from the one used for main vaccination can be allowed within the nation.
“Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for those aged above 18 years enabling use of Corbevax as a heterologous COVID-19 vaccine for precaution dose administration in this age group,” a supply stated.
This might be along with the present tips for homologous precaution dose administration of Covaxin and Covishield vaccines.
India’s first indigenously developed RBD protein subunit vaccine Corbevax is presently getting used to inoculate kids within the age group of 12 to 14 years below the COVID-19 immunisation programme.
The COVID-19 Working Group (CWG), in its July 20 assembly, reviewed information of the double-blind randomized phase-3 scientific examine which evaluated the immunogenicity and security of booster dose of Corbevax vaccine when administered to COVID-19-negative grownup volunteers of age 18-80 years beforehand vaccinated with two doses of both Covishield or Covaxin.
“Following the examination of the data, the CWG observed that Corbevax vaccine can induce significant increase in antibody titers when given to those who have received either Covaxin or Covishield, which is likely to be protective as per the neutralization data also,” the supply stated.
The Drugs Controller General of India (DCGI) on June 4 authorised Corbevax as a precaution dose for these aged 18 and above.
India started administering precaution doses of vaccines to healthcare and frontline employees and people aged 60 and above with comorbidities from January 10.
The nation started inoculating kids aged 12-14 from March 16 and in addition eliminated the comorbidity clause making all individuals aged above 60 eligible for the precaution dose of Covid vaccine.
India on April 10 started administering precaution doses of COVID-19 vaccines to all aged above 18 years.
NEW DELHI: The Union well being ministry is anticipated to quickly approve Biological E’s Corbevax as a precaution dose for individuals above 18 years who’re double vaccinated with both Covishield or Covaxin, official sources stated on Tuesday.
The approval might be primarily based on the suggestions made by the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) final week, the sources instructed PTI.
If authorised by the federal government, this might be the primary time a booster dose of a Covid vaccine totally different from the one used for main vaccination can be allowed within the nation.
“Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for those aged above 18 years enabling use of Corbevax as a heterologous COVID-19 vaccine for precaution dose administration in this age group,” a supply stated.
This might be along with the present tips for homologous precaution dose administration of Covaxin and Covishield vaccines.
India’s first indigenously developed RBD protein subunit vaccine Corbevax is presently getting used to inoculate kids within the age group of 12 to 14 years below the COVID-19 immunisation programme.
The COVID-19 Working Group (CWG), in its July 20 assembly, reviewed information of the double-blind randomized phase-3 scientific examine which evaluated the immunogenicity and security of booster dose of Corbevax vaccine when administered to COVID-19-negative grownup volunteers of age 18-80 years beforehand vaccinated with two doses of both Covishield or Covaxin.
“Following the examination of the data, the CWG observed that Corbevax vaccine can induce significant increase in antibody titers when given to those who have received either Covaxin or Covishield, which is likely to be protective as per the neutralization data also,” the supply stated.
The Drugs Controller General of India (DCGI) on June 4 authorised Corbevax as a precaution dose for these aged 18 and above.
India started administering precaution doses of vaccines to healthcare and frontline employees and people aged 60 and above with comorbidities from January 10.
The nation started inoculating kids aged 12-14 from March 16 and in addition eliminated the comorbidity clause making all individuals aged above 60 eligible for the precaution dose of Covid vaccine.
India on April 10 started administering precaution doses of COVID-19 vaccines to all aged above 18 years.
